# King Pharmaceuticals LLC, Rochester, MI – FDA Inspections

Source: https://www.keypedia.com/companies/king-pharmaceuticals-llc/d90c79dd-4325-4185-bf42-87c7f116f6c5

> Inspection records and compliance data for King Pharmaceuticals LLC in Rochester, Michigan. 11 FDA inspections on record (2 OAI), 2 Form 483s, last inspected February 18, 2025.

---

## Details

- Name: King Pharmaceuticals LLC
- FEI Number: 1876582
- Canada Business Number: 814881744
- Business Operations: FDF MANUFACTURE
- Address Line 1: 1200 Parkdale Rd
- City: Rochester
- State: Michigan
- Zip Code: 48307
- Country Name: United States
- Address: 1200 Parkdale Rd, Rochester, Michigan 48307, United States
- Country: United States

## Related Documents

- [483 - King Pharmaceuticals LLC - 2025-02-18](https://www.keypedia.com/records/483/king-pharmaceuticals-llc/0b1a81a9-74c5-4125-9ef6-34fc1bcd7429) — source: FDA, date: February 18, 2025
- [FDA Inspection 1261579 - King Pharmaceuticals LLC - 2025-02-18](https://www.keypedia.com/records/fda_inspections/king-pharmaceuticals-llc/e5c72c4e-54fe-4484-bed9-03e7d9adb0d4) — classification: Official Action Indicated (OAI), source: FDA, date: February 18, 2025
- [483 - King Pharmaceuticals LLC - 2019-10-21](https://www.keypedia.com/records/483/king-pharmaceuticals-llc/589209b1-870a-4c6a-8718-de4e70e013db) — source: FDA, date: October 21, 2019
- [FDA Inspection 1107986 - King Pharmaceuticals LLC - 2019-10-21](https://www.keypedia.com/records/fda_inspections/king-pharmaceuticals-llc/58f418d8-9ca1-4be2-855a-7bc1a490a62d) — classification: Voluntary Action Indicated (VAI), source: FDA, date: October 21, 2019
- FDA Inspection 1049269 - King Pharmaceuticals LLC - 2018-03-14 — classification: No Action Indicated (NAI), source: FDA, date: March 14, 2018
- [FDA Inspection 1000037 - King Pharmaceuticals LLC - 2016-11-21](https://www.keypedia.com/records/fda_inspections/king-pharmaceuticals-llc/59536aff-e7e2-4946-95f5-65e155fc801b) — classification: Voluntary Action Indicated (VAI), source: FDA, date: November 21, 2016
- [FDA Inspection 926523 - King Pharmaceuticals LLC - 2015-05-15](https://www.keypedia.com/records/fda_inspections/king-pharmaceuticals-llc/4bc99bb3-adf2-4e83-a761-5401e8d9ef2c) — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 15, 2015
- [FDA Inspection 892667 - King Pharmaceuticals LLC - 2014-08-26](https://www.keypedia.com/records/fda_inspections/king-pharmaceuticals-llc/347aea7a-3f84-4348-96af-67e02cca1cc4) — classification: Voluntary Action Indicated (VAI), source: FDA, date: August 26, 2014
- [FDA Inspection 807158 - King Pharmaceuticals LLC - 2012-12-13](https://www.keypedia.com/records/fda_inspections/king-pharmaceuticals-llc/3c7b4bcb-ac1d-48b3-bb5a-0fb4657b5643) — classification: Voluntary Action Indicated (VAI), source: FDA, date: December 13, 2012
- [FDA Inspection 786574 - King Pharmaceuticals LLC - 2012-06-15](https://www.keypedia.com/records/fda_inspections/king-pharmaceuticals-llc/4c1de0ec-f665-43b9-ae67-4c0c3cbe8959) — classification: Voluntary Action Indicated (VAI), source: FDA, date: June 15, 2012
- [FDA Inspection 713757 - King Pharmaceuticals LLC - 2011-03-16](https://www.keypedia.com/records/fda_inspections/king-pharmaceuticals-llc/6a50e321-51c5-4502-b50c-9f41d1bdca03) — classification: Voluntary Action Indicated (VAI), source: FDA, date: March 16, 2011
- [FDA Inspection 638769 - King Pharmaceuticals LLC - 2010-01-19](https://www.keypedia.com/records/fda_inspections/king-pharmaceuticals-llc/6d18c07e-39c1-4d09-b4ca-4c7f5290b6d3) — classification: Official Action Indicated (OAI), source: FDA, date: January 19, 2010

## Related Companies

- [Padagis US LLC](https://www.keypedia.com/companies/padagis-us-llc/d356236a-0058-4d8b-86ad-56011f641c96)
- [Sun Pharmaceutical Industries, Inc.](https://www.keypedia.com/companies/sun-pharmaceutical-industries-inc/1a56d6cb-288c-42d5-9558-e4301ffebc65)
- [Nostrum Laboratories, Inc.](https://www.keypedia.com/companies/nostrum-laboratories-inc/c9042755-fe46-4113-b071-6c8168af53e2)
- [Haleon US Holdings LLC](https://www.keypedia.com/companies/haleon-us-holdings-llc/adf0ad1b-ed79-4d72-a254-d42d5a982384)
- [Actavis Laboratories FL, Inc.](https://www.keypedia.com/companies/actavis-laboratories-fl-inc/7c50db23-6cc7-4100-bc80-c02d3aa7f85a)
- [Rovi Pharma Industrial Services S.A.](https://www.keypedia.com/companies/rovi-pharma-industrial-services-sa/92dc52fe-a8d7-4a23-bc34-be68892d8866)
- [Sanofi Winthrop Industrie](https://www.keypedia.com/companies/sanofi-winthrop-industrie/88a4c8ee-d792-4747-acb7-de304d1efbb6)
- [Daiichi Sankyo Europe GmbH](https://www.keypedia.com/companies/daiichi-sankyo-europe-gmbh/772636a4-cbb8-47ae-8aa1-fdc45ab325f6)
- [PF Soins de Sante SRI](https://www.keypedia.com/companies/pf-soins-de-sante-sri/9e60bbed-a0ce-4353-ae08-a599608d5bd4)
- [Janssen - Cilag Spa.](https://www.keypedia.com/companies/janssen-cilag-spa/56d16030-02d8-414b-8438-54033c2e5f91)

## Related Officers

- [Alan M. Roberts](https://www.keypedia.com/people/alan-m-roberts/b6565c30-6228-4f51-a1b7-369bffe54e9c)
- [Associate Director](https://www.keypedia.com/people/jeffrey-d-meng/55543677-bd74-4cc5-8a2a-e14afb91d338)
- [Nicholas J. Presto](https://www.keypedia.com/people/nicholas-j-presto/2ecdd573-6662-4d07-b93c-ddb9c603bcfa)
- [Investigator](https://www.keypedia.com/people/jacob-g-lutz/ca2710c6-064f-4728-9129-aad73e74f12d)